Diaphragmatic perforation after transcatheter arterial chemoembolization of hepatocellular carcinoma via inferior phrenic artery: a case report

[1]  Keerati Hongsakul,et al.  Impact of cone-beam computed tomography with automated feeder detection software on the survival outcome of patients with hepatocellular carcinoma during treatment with conventional transarterial chemoembolization , 2021, BMC Gastroenterology.

[2]  F. Piscaglia,et al.  TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular Carcinoma , 2021, Journal of personalized medicine.

[3]  Sangjoon Lee,et al.  Effectiveness of intraprocedural dual-phase cone-beam computed tomography in detecting hepatocellular carcinoma and improving treatment outcomes following conventional transarterial chemoembolization , 2021, PloS one.

[4]  R. Golfieri,et al.  Standardization of Conventional Chemoembolization for Hepatocellular Carcinoma. , 2020, Annals of hepatology.

[5]  Jun Kato,et al.  Switching to systemic therapy after locoregional treatment failure: Definition and best timing , 2020, Clinical and molecular hepatology.

[6]  F. Piscaglia,et al.  Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients. , 2019, Journal of hepatology.

[7]  D. Madoff,et al.  Balloon-Assisted Blood Pressure Reduction in the Downstream Vascular Compartment to Avoid Nontarget Embolization during Transarterial Chemoembolization from the Inferior Phrenic Artery. , 2019, Journal of vascular and interventional radiology : JVIR.

[8]  Y. Tsushima,et al.  Imaging findings and complications of transcatheter interventional treatments via the inferior phrenic arteries in patients with hepatocellular carcinoma , 2018, European journal of radiology open.

[9]  Y. Kodama,et al.  Multicenter Phase II Clinical Trial of Sorafenib Combined with Transarterial Chemoembolization for Advanced Stage Hepatocellular Carcinomas (Barcelona Clinic Liver Cancer Stage C): STAB Study. , 2018, Journal of vascular and interventional radiology : JVIR.

[10]  F. Piscaglia,et al.  Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib , 2018, European Radiology.

[11]  Y. Akagi,et al.  Surgically treated diaphragmatic perforation after radiofrequency ablation for hepatocellular carcinoma , 2017, World journal of gastrointestinal surgery.

[12]  F. Piscaglia,et al.  Transarterial chemoembolization vs bland embolization in hepatocellular carcinoma: A meta-analysis of randomized trials , 2017, United European gastroenterology journal.

[13]  Z. Jia,et al.  The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma , 2016, Medicine.

[14]  Y. Chai,et al.  Delayed iatrogenic diaphragmatic hernia after thoracoscopic lobectomy. , 2016, Journal of thoracic disease.

[15]  T. Murakami,et al.  Surgical and Locoregional Therapy of HCC: TACE , 2015, Liver Cancer.

[16]  R. Golfieri,et al.  Calculation of conversion factors for effective dose for various interventional radiology procedures. , 2012, Medical physics.

[17]  N. Seong,et al.  Chemoembolization of the left inferior phrenic artery in patients with hepatocellular carcinoma: 9-year single-center experience. , 2010, AJR. American journal of roentgenology.

[18]  F. Rashid,et al.  A review on delayed presentation of diaphragmatic rupture , 2009, World journal of emergency surgery : WJES.

[19]  C. Yoon,et al.  Development of diaphragmatic weakness after transcatheter arterial chemoembolization of the right inferior phrenic artery: frequency and determinant factors. , 2009, Journal of vascular and interventional radiology : JVIR.

[20]  R. Tubbs,et al.  A review of the distribution of the arterial and venous vasculature of the diaphragm and its clinical relevance. , 2008, Folia morphologica.

[21]  Jung-Hwan Yoon,et al.  Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma: Prevalence and Causative Factors of Extrahepatic Collateral Arteries in 479 Patients , 2006, Korean journal of radiology.

[22]  Sung W. Shin,et al.  Diaphragmatic weakness after transcatheter arterial chemoembolization of inferior phrenic artery for treatment of hepatocellular carcinoma. , 2006, Radiology.

[23]  Jong Tae Lee,et al.  Chemoembolization of the left inferior phrenic artery in patients with hepatocellular carcinoma: radiographic findings and clinical outcome. , 2005, Journal of vascular and interventional radiology : JVIR.

[24]  Jin Wook Chung,et al.  Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization. , 2005, Radiographics : a review publication of the Radiological Society of North America, Inc.

[25]  F. Walter,et al.  Imaging of diaphragmatic injury: a diagnostic challenge? , 2002, Radiographics : a review publication of the Radiological Society of North America, Inc.

[26]  H. Luckraz,et al.  A review diaphragmatic injury , 2009 .